Turn Therapeutics Inc. (TTRX)

NASDAQ: TTRX · Real-Time Price · USD

4.820

+0.080 (1.69%)

Jan 15, 2026, 4:00 PM EST - Market closed

Turn Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Admin	3.75	1.55	2.3	4.21
Research & Development	0.24	0.25	0.01	-
Operating Expenses	3.99	1.8	2.31	4.21
Operating Income	-3.99	-1.8	-2.31	-4.21
Interest Expense	-	-	-	-0.09
Interest & Investment Income	0.02	0.03	0.02	0.01
Pretax Income	-3.8	-1.77	-2.29	-4.29
Income Tax Expense	-	-	-	0
Net Income	-3.8	-1.77	-2.29	-4.29
Net Income to Common	-3.8	-1.77	-2.29	-4.29
Shares Outstanding (Basic)	28	27	26	-
Shares Outstanding (Diluted)	28	27	26	-
Shares Change (YoY)	3.81%	1.33%	-	-
EPS (Basic)	-0.14	-0.07	-0.09	-
EPS (Diluted)	-0.14	-0.07	-0.09	-
EBITDA	-3.94	-1.75	-2.26	-4.16
D&A For EBITDA	0.05	0.05	0.04	0.05
EBIT	-3.99	-1.8	-2.31	-4.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q